active
ACTIVE SINCE: 2021
Back to Collaborations

Bristol Myers Squibb Foundation: Improving Early Cancer Diagnosis in Brazil

The project will identify at-risk populations, develop new diagnostic pathways and patient navigation programs to reduce time between suspicion, diagnosis, and treatment of lung and skin cancers.
SGDS CONTRIBUTING TO:
MEMBER COMPANIES:
PARTNERING WITH:
SEE ALL PARTNER ORGANIZATIONS
Global NGOs 1
Pharma Company Foundation 1

The project will identify at-risk populations, develop new diagnostic pathways and patient navigation programs to reduce time between suspicion, diagnosis, and treatment of lung and skin cancers.

Results and milestones
  • Capacity development in Primary Healthcare professional: tranining workshops conducted with 45 HCPs trained to date
  • Development of New Rapid Diagnostic Pathway: 2 Red Flag Protocols and decision tree developed for lung cancer and melanoma. 1 app in development for use in basic health units connecting HCPs to specialists, for identification and flagging of priority patients.
  • Patient navigation programs developed for lung cancer and melanoma
Geographic Reach
  • Americas
See Where
Disease Area
  • Non-communicable Diseases
See Disease Areas
SGDs the partnership contributes to
SDG 3: Good Health and Wellbeing
  1. 3.4: NCDs (including mental health)
  2. 3.8: Achieve universal health coverage
SDG 17: Partnerships for the Goals 
Partner organizations
Global NGOs

City Cancer Challenge

Pharma Company Foundation

Bristol Myers Squibb Foundation

Geographic Reach

Americas

  • Brazil

Disease Area

Non-communicable Diseases

  • Cancer
    • Lung Cancer
    • Melanoma